2012
DOI: 10.1111/aji.12001
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of HLA‐G Polymorphisms in Couples with Implantation Failure

Abstract: The results suggest that the distribution of HLA-G products may play a significant role in the modulation of maternal-fetal immune response.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 30 publications
(13 citation statements)
references
References 32 publications
0
13
0
Order By: Relevance
“…HLA‐G downregulation is a prognostic marker for obstetric complications such as fetal growth restriction and spontaneous abortions . Significantly, lower concentrations of sHLA‐G were found in preeclamptic pregnancies with respect to the controls, when measured at the first, second, and third trimester, and this was recently correlated with oxidative stress .…”
Section: Discussionmentioning
confidence: 97%
“…HLA‐G downregulation is a prognostic marker for obstetric complications such as fetal growth restriction and spontaneous abortions . Significantly, lower concentrations of sHLA‐G were found in preeclamptic pregnancies with respect to the controls, when measured at the first, second, and third trimester, and this was recently correlated with oxidative stress .…”
Section: Discussionmentioning
confidence: 97%
“…To date, more than 20 reports have described a variety of genetic variants associated or not with the risk of recurrent implantation failure (RIF) in patients undergoing IVF, comparing alleles frequencies between patients with RIF and control group (Table S1). These risk factors include single nucleotide polymorphisms (SNPs) in the genes for tumour suppressor protein 53 [10][12], follicle-stimulating hormone receptor (FSHR) [13], [14], methylenetetrahydrofolate reductase (MTHFR) [15][17], human leukocyte antigen-G (HLA-G) [18], [19], vascular endothelial growth factor (VEGF) [20], [21], plasminogen activator inhibitor-1 (PAI) [20], progesterone receptor (PR) [22], [23], and cyclooxygenase-2 (COX-2) [24], serotonin transporter (SERT) and serotonin receptor 1A (5-HT1A) [25]. Moreover, it was recently suggested that the implantation process depends on combinations of several genetic and environmental factors.…”
Section: Introductionmentioning
confidence: 99%
“…The HLA‐G gene has already been studied by our research group in different context of reproductive immunogenetics (assisted reproduction treatment, implantation failure and recurrent miscarriage) with results published by Costa et al ,. by Nardi et al . and by Vargas et al …”
Section: Discussionmentioning
confidence: 87%